More News

21 Dec 2018 Xynomic Pharma Acquires Global Exclusive Rights to Phase 2 Ready mTORC1/2 Inhibitor from Boehringer Ingelheim
20 Dec 2018 Roivant Sciences and Daiichi Sankyo Enter into Broad Pipeline Partnership
20 Dec 2018 Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
20 Dec 2018 Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company
20 Dec 2018 Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies
20 Dec 2018 Ayala Pharmaceuticals Signs Deal to Develop and Commercialize AL102 in Combination with BCMA Targeting Agents in Multiple Myeloma
20 Dec 2018 Tetra Discovery Partners and Shionogi & Co., Ltd. Collaborate on BPN14770 Development and Commercialization
20 Dec 2018 Gilead Sciences and Scholar Rock Announce Strategic Collaboration to Develop Novel Therapies for Fibrotic Diseases
20 Dec 2018 Akaal Pharma Pty Ltd Announces Licensing Agreement for its First-in-Class, Topical Spingosine-1-Phosphate-1 (S1P1) Receptor Modulator for Atopic Dermatitis and Psoriasis
20 Dec 2018 X-Chem enters strategic collaboration with Bristol-Myers Squibb
19 Dec 2018 Pyramid Biosciences Announces Exclusive Global License of AstraZeneca TRK Program for Dermatology and Inflammatory Diseases
19 Dec 2018 Kineta Enters Research Collaboration and License Agreement with Pfizer to Develop New Cancer Immunotherapies
19 Dec 2018 Bridge Biotherapeutics Signs US$40M License Agreement with Daewoong Pharmaceutical for Co-development of UC Drug Candidate
19 Dec 2018 AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partnership
19 Dec 2018 Ligand Acquires Milestone and Royalty Rights to PTX-022 from Palvella Therapeutics
19 Dec 2018 Horizon Discovery Group plc enters an exclusive partnership with C4X Discovery Holdings plc to validate targets and develop next-generation oncology drugs
19 Dec 2018 Daiichi Sankyo Out-Licenses ROS1/NTRK Inhibitor DS-6051 to AnHeart Therapeutics
19 Dec 2018 Sandoz enters into commercialization and supply agreement for insulin biosimilars, anticipating growing demand as diabetes burden rises
19 Dec 2018 Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies
19 Dec 2018 Amgen And Molecular Partners Announce Strategic Collaboration In Immuno-Oncology
17 Dec 2018 Bristol-Myers Squibb and H3 Biomedicine Announce Research Collaboration to Advance Novel Therapeutics Leveraging H3’s RNA Splicing Platform
17 Dec 2018 Proteostasis Therapeutics Announces Global License Agreement with Genentech
17 Dec 2018 Staten Biotechnology B.V. and Novo Nordisk A/S announce collaboration to develop novel treatment for dyslipidaemia
15 Dec 2018 Prestige BioPharma Partners with Cipla Ltd to Market Key Cancer Biosimilar
14 Dec 2018 Adaptive Phage Therapeutics Enters into Collaboration Agreement with Researchers at Yale University to Manufacture and Supply Therapeutic Bacteriophage

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up